145 related articles for article (PubMed ID: 14991835)
21. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection.
Witting A; Chen L; Cudaback E; Straiker A; Walter L; Rickman B; Möller T; Brosnan C; Stella N
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6362-7. PubMed ID: 16571660
[TBL] [Abstract][Full Text] [Related]
22. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
Ji Q; Goverman J
Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
[TBL] [Abstract][Full Text] [Related]
23. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis.
Lavasani S; Dzhambazov B; Andersson M
Scand J Immunol; 2007 Jan; 65(1):39-47. PubMed ID: 17212765
[TBL] [Abstract][Full Text] [Related]
25. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis.
Wheeler RD; Zehntner SP; Kelly LM; Bourbonnière L; Owens T
Immunology; 2006 Aug; 118(4):527-38. PubMed ID: 16780563
[TBL] [Abstract][Full Text] [Related]
26. Induction of EAE by T cells specific for alpha B-crystallin depends on prior viral infection in the CNS.
Verbeek R; van Dongen H; Wawrousek EF; Amor S; van Noort JM
Int Immunol; 2007 Mar; 19(3):277-85. PubMed ID: 17267417
[TBL] [Abstract][Full Text] [Related]
27. Lessons from multiple sclerosis: models, concepts, observations.
Wekerle H
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii56-60. PubMed ID: 19022815
[TBL] [Abstract][Full Text] [Related]
28. IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis.
Liu R; Bai Y; Vollmer TL; Bai XF; Jee Y; Tang YY; Campagnolo DI; Collins M; Young DA; La Cava A; Shi FD
Exp Neurol; 2008 May; 211(1):14-24. PubMed ID: 18353312
[TBL] [Abstract][Full Text] [Related]
29. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).
Tutaj M; Szczepanik M
J Autoimmun; 2007 Jun; 28(4):208-15. PubMed ID: 17442539
[TBL] [Abstract][Full Text] [Related]
30. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis.
Karpus WJ; Ransohoff RM
J Immunol; 1998 Sep; 161(6):2667-71. PubMed ID: 9743321
[TBL] [Abstract][Full Text] [Related]
31. Protection from autoimmunity by DNA vaccination against T-cell receptor.
Buch T; Waisman A
Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460
[TBL] [Abstract][Full Text] [Related]
32. Exploiting genotypic differences to identify genes important for EAE development.
Jelinsky SA; Miyashiro JS; Saraf KA; Tunkey C; Reddy P; Newcombe J; Oestreicher JL; Brown E; Trepicchio WL; Leonard JP; Marusic S
J Neurol Sci; 2005 Dec; 239(1):81-93. PubMed ID: 16214174
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
Thessen Hedreul M; Gillett A; Olsson T; Jagodic M; Harris RA
J Neuroimmunol; 2009 May; 210(1-2):30-9. PubMed ID: 19269041
[TBL] [Abstract][Full Text] [Related]
34. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
35. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
36. CD8+ T cells in inflammatory demyelinating disease.
Weiss HA; Millward JM; Owens T
J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
[TBL] [Abstract][Full Text] [Related]
37. The FcRgamma chain is not essential for induction of experimental allergic encephalomyelitis (EAE) or anti-myelin antibody-mediated exacerbation of EAE.
Breij EC; Heijnen P; Vloet R; Saito T; van de Winkel JG; Dijkstra CD; Amor S; Verbeek S
J Neuropathol Exp Neurol; 2005 Apr; 64(4):304-11. PubMed ID: 15835266
[TBL] [Abstract][Full Text] [Related]
38. Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors.
Urich E; Gutcher I; Prinz M; Becher B
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18697-702. PubMed ID: 17121989
[TBL] [Abstract][Full Text] [Related]
39. T-cells in multiple sclerosis.
Severson C; Hafler DA
Results Probl Cell Differ; 2010; 51():75-98. PubMed ID: 19582415
[TBL] [Abstract][Full Text] [Related]
40. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis.
Owens T; Sriram S
Neurol Clin; 1995 Feb; 13(1):51-73. PubMed ID: 7739505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
